ReviewBMJ digital health & AI2026
State of clinical AI in 2026.
Review in BMJ digital health & AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical artificial intelligence (AI) has advanced rapidly, with frontier large language models now matching or exceeding physician performance on simulated diagnostic reasoning and clinical decision-support tasks. Yet adoption has outpaced the evidence base: fewer than 5% of cleared U.S. Food and Drug Administration (FDA) AI/machine learning (ML) devices have undergone peer-reviewed evaluation and prospective randomised trials remain scarce. This narrative review synthesises evidence from ARISE's State of Clinical AI Report 2026 across six domains: model performance and human benchmarking, evaluation methodology and benchmark validity, foundational methods including multimodal and multiagent systems, clinical workflow integration, patient-facing applications and applied domain-specific AI. We conducted a targeted literature search of PubMed, medRxiv and arXiv supplemented by expert nomination, including empirical studies of AI in clinical contexts. Across domains, frontier models demonstrate strong clinical reasoning capabilities but exhibit persistent failures in uncertainty calibration, metacognition and robustness to distributional shift. Standard benchmarks have saturated, prompting development of multidimensional evaluation frameworks that assess safety, real-world workflows and agentic capabilities. New trends in foundational methods include converting medical data into tokens and developing multiagent, multimodal systems. In clinical workflows, early prospective trials in clinical decision support and diagnostic imaging show promising results, though human-AI collaboration remains suboptimal and risks of automation bias and clinician deskilling are emerging. In tandem, patient-facing AI is progressing with more personalised health assistance; with this comes the risk of patient overtrust, raising the bar for guardrails. The most credible translational progress occurs on narrowly defined tasks with clear endpoints, while broader clinical autonomy awaits advances in evaluation and human-AI interaction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.